---
title: "Blue Chip India Ltd (BLUECHIP) — Share Price, Financials & Analysis"
symbol: "BLUECHIP"
company: "Blue Chip India Ltd"
canonical: "https://tapetide.com/stocks/BLUECHIP"
isin: "INE657B01025"
nse_symbol: "BLUECHIP"
bse_code: "531936"
sector: "Financial Services"
industry: "Finance"
market_cap_cr: 11.61
generated_at: "2026-09-13T18:45:08.863Z"
---

# Blue Chip India Ltd (BLUECHIP)

Canonical page: https://tapetide.com/stocks/BLUECHIP

## Company

- **NSE Symbol:** BLUECHIP
- **BSE Code:** 531936
- **ISIN:** INE657B01025
- **Sector:** Financial Services
- **Industry:** Finance
- **Macro Sector:** Financial Services
- **Stock Type:** EQUITY
- **Listed Since:** 1997-03-12
- **CEO:** Mr. Arihant Jain
- **Employees:** 5
- **Face Value:** ₹2
- **F&O Eligible:** No
- **Website:** bluechipind.net

## About

Incorporated in 1993, Blue Chip India Ltd is in the business of fund-based activities.[1]

## Latest Price

- **Price:** ₹2.1
- **Change:** -0.04 (-1.87%)
- **Open:** ₹2.1
- **Day High:** ₹2.1
- **Day Low:** ₹2.1
- **Previous Close:** ₹2.14
- **Volume:** 3773
- **As Of:** 2026-09-07T07:57:18+00:00

## Key Fundamentals

Observed at 2026-09-07T04:33:37.637243Z.

- **Market Cap:** ₹11.61 Cr
- **Classification:** Microcap
- **P/E (reported):** -31.6
- **EPS (TTM):** ₹-0.07
- **Book Value:** ₹-0.12
- **Price to Book:** -17.74
- **Dividend Yield:** 0%
- **ROE:** 375.78%
- **ROCE:** 375.78%
- **Debt to Equity:** 0
- **Revenue (yearly):** ₹0.18 Cr
- **Net Income:** ₹-0.28 Cr
- **EBITDA:** ₹-0.35 Cr
- **52-Week High:** ₹4.32
- **52-Week Low:** ₹1.65

## Key Insights

### Weaknesses

- Company has low interest coverage ratio.
- Promoter holding is low: 11.2%

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | -100% | 96.43% | -101.09% |
| ebitda margin growth | -300% | 9.88% | 19.39% | -93.98% |
| net income growth | -300% | -89.23% | -16% | 1% |
| revenue growth | -100% | 80% | 69% | — |
| roce | — | -359.52% | — | 43.48% |
| roe | — | -359.52% | 81.79% | — |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.18 | 0 |
| Expenses | 0.03 | 0.03 | 0.04 | 0.1 | 0.01 | 0.03 | 0.06 | 0.13 | 0.18 | 0.11 | 0.1 | 0.22 |
| Operating Profit | -0.03 | -0.03 | -0.04 | -0.1 | -0.01 | -0.03 | -0.06 | -0.13 | -0.18 | -0.11 | 0.08 | -0.22 |
| OPM % | — | — | — | — | — | — | — | — | — | — | 44.44 | — |
| Other Income | 0.01 | 0.05 | 0.04 | 0.06 | 0 | 0 | -2.46 | 0.03 | 0.02 | 0.01 | 0.01 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | -0.02 | 0.02 | 0 | -0.04 | -0.01 | -0.03 | -2.52 | -0.1 | -0.16 | -0.1 | 0.09 | -0.22 |
| Tax % | 0 | 0 | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -0.02 | 0.02 | 0 | -0.04 | -0.01 | -0.03 | -2.52 | -0.1 | -0.16 | -0.1 | 0.09 | -0.22 |
| EPS in Rs | 0 | 0 | 0 | -0.01 | 0 | -0.01 | -0.46 | -0.02 | -0.03 | -0.02 | 0.02 | -0.04 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 0.3 | 0.03 | 0 | 0 | 0.01 | 0.05 | 0.1 | 0.09 | 0.24 | 0.18 |
| Expenses | 0.48 | 0.4 | 1.25 | 0.29 | 0.26 | 0.25 | 0.22 | 0.21 | 0.4 | 0.61 |
| Operating Profit | -0.18 | -0.37 | -1.25 | -0.29 | -0.25 | -0.2 | -0.12 | -0.12 | -0.16 | -0.43 |
| OPM % | -60 | -1233.33 | — | — | -2500 | -400 | -120 | -133.33 | -66.67 | -238.89 |
| Other Income | 0.06 | 0 | 0 | 0 | 0 | 0.89 | -2.82 | -2.49 | 0.01 | 0.04 |
| Interest | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 | 0.13 | 0 |
| Depreciation | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | -0.13 | -0.37 | -1.25 | -0.3 | -0.25 | 0.69 | -2.94 | -2.61 | -0.28 | -0.39 |
| Tax % | 0 | 2.7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |
| Net Profit | -0.13 | -0.38 | -1.25 | -0.3 | -0.25 | 0.69 | -2.94 | -2.61 | -0.28 | -0.39 |
| EPS in Rs | -0.02 | -0.07 | -0.23 | -0.05 | -0.05 | 0.12 | -0.53 | -0.47 | -0.05 | -0.07 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 11.06 | 11.06 | 11.06 | 11.06 | 11.06 | 11.06 | 11.06 | 11.06 | 11.06 | 11.06 |
| Reserves | -10.01 | -10.13 | -8.25 | -11.25 | -9.67 | -7.19 | -6.27 | -9.03 | -11.75 | -11.75 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 5.5 | 5.01 | 5.33 | 5.63 | 5.89 | 6.16 | 4.69 | 4.67 | 5.82 | 4.22 |
| Total Liabilities | 6.55 | 5.94 | 8.14 | 5.44 | 7.28 | 10.03 | 9.48 | 6.7 | 5.13 | 3.53 |
| Fixed Assets | 0.03 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 2.27 | 1.71 | 3.97 | 1.27 | 3.14 | 5.9 | 6.15 | 0.73 | 0.62 | 0.35 |
| Other Assets | 4.25 | 4.21 | 4.15 | 4.16 | 4.13 | 4.12 | 3.32 | 5.96 | 4.5 | 3.17 |
| Total Assets | 6.55 | 5.94 | 8.14 | 5.44 | 7.28 | 10.03 | 9.48 | 6.7 | 5.13 | 3.53 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | -0.03 | -0.55 | -0.32 | -2.69 | 1.84 | 2.76 | -0.56 | -0.01 | -0.02 | -0.42 |
| Cash from Investing Activity | 0 | 0.56 | 0.28 | 2.7 | -1.87 | -2.76 | -0.25 | 0.05 | 0 | 0.41 |
| Cash from Financing Activity | 0 | 0 | 0.02 | -0.01 | 0.05 | 0 | 0.8 | 0 | 0 | 0 |
| Net Cash Flow | -0.03 | 0.01 | -0.02 | 0 | 0.02 | 0 | -0.01 | 0.04 | -0.02 | -0.01 |
| Free Cash Flow | -0.03 | -0.55 | -0.32 | 0.01 | 1.84 | 2.76 | -0.56 | -0.01 | -0.02 | -0.42 |
| CFO/OP | 12 | 306 | 86 | 215 | -634 | -1104 | 280 | 8 | 17 | 262 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 0 | 12.17 | 0 | — | — | 0 | 0 | 0 | 0 | 0 |
| Inventory Days | 0.64 | 91.25 | — | — | — | — | — | — | — | — |
| Days Payable | 0 | 0 | — | — | — | — | — | — | — | — |
| Cash Conversion Cycle | 0.64 | 103.42 | 0 | — | — | 0 | 0 | 0 | 0 | 0 |
| Working Capital Days | -276.25 | -4830.17 | -63388.33 | — | — | -221190 | -33434 | -6971.5 | -23035.56 | -6159.38 |
| ROCE % | -21.76 | -13.13 | -19.79 | -95.42 | -48.33 | -9.51 | -4.62 | -3.52 | -17.91 | — |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 11.25% | 11.25% | 11.25% | 11.25% | 11.25% | 11.25% | 11.25% | 11.25% | 11.25% | 11.25% | 11.25% | 11.25% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 63.05% | 62.9% | 63.27% | 63.81% | 65.43% | 65.66% | 65.85% | 65.81% | 65.82% | 65.78% | 65.72% | 65.8% |
| Others | 25.7% | 25.86% | 25.48% | 24.94% | 23.32% | 23.09% | 22.91% | 22.94% | 22.93% | 22.97% | 23.03% | 22.95% |
| No. of Shareholders | 15968 | 16850 | 20125 | 22782 | 30503 | 36003 | 41781 | 42065 | 42098 | 42114 | 41448 | 40850 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Buy
- **Buy / Neutral / Sell:** 8 / 5 / 6

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 2.06 | Buy |
| EMA (10) | 2.06 | Buy |
| SMA (20) | 1.92 | Buy |
| EMA (20) | 1.99 | Buy |
| SMA (50) | 2.03 | Buy |
| EMA (50) | 2.06 | Buy |
| SMA (100) | 2.44 | Sell |
| EMA (100) | 2.44 | Sell |
| SMA (200) | 3.4 | Sell |
| EMA (200) | 3.32 | Sell |

### Oscillators — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 60.35 | Neutral |
| MACD (12,26,9) | 0.05 | Buy |
| Stochastic (14,3,3) | 89.46 | Sell |
| ADX (14) | 20.71 | Neutral |
| Williams %R (14) | -21.62 | Neutral |
| ATR (14) | 0.04 | Neutral |
| ROC (12) | 14.13 | Buy |
| Stoch RSI (14) | 64.12 | Neutral |
| UO (7,14,28) | 72.5 | Sell |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-07 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e14d8fdb-28a7-4c0c-8eff-09616bbedbea.pdf) |
| 2026-09-04 | [INTIMATION OF BOOK CLOSURE OF 41St AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=027b8abe-bb9a-4ae6-ae01-8fd8f0a056b8.pdf) |
| 2026-09-04 | [ANNUAL GENERAL MEETING (AGM) INTIMATION FOR FINANCIAL YEAR 2025-26](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6098e9de-eaa1-46d6-b91d-0025be8f9b14.pdf) |
| 2026-09-04 | [NOTICE OF 41St ANNUAL GENERAL MEETING TO BE HELD ON 28/09/2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dc2c2da3-8fb7-4bec-8e7f-17f3f4ef6178.pdf) |
| 2026-09-04 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b5f18db9-13a3-437f-8649-b96f62f60b77.pdf) |
| 2026-08-17 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9a8e36bd-060a-41dd-b8ee-1b811f308790.pdf) |
| 2026-08-14 | [Board Meeting Outcome for Board Meeting Dated 14/08/2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2ac40412-6738-4506-a3d7-d091416a6f5e.pdf) |
| 2026-08-14 | [Appointment For Secretarial Auditor M/S Suprabhat & Co.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0bff46b4-c19a-42f5-bdda-7056c705ccc6.pdf) |
| 2026-08-14 | [Appointment Of Ms. Asha Pal As The Chief Financial Officer (CFO) W.E.F 14Th August 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0b2a8c34-389f-4bf5-85d4-a2bbdf273f59.pdf) |
| 2026-08-14 | [Announcement under Regulation 30 (LODR)-Change in Directorate](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=26b7a36f-4911-4200-a49e-2a8756f21183.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-14 | [Unaudited Financial Result For Quarter Ended 30Th June 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f1b565ef-63de-470a-ad9d-d7ec9075371c.pdf) |
| 2026-02-12 | [Financial Results For The Quarter Ended 31.12.2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=130649d6-60ca-47ab-b8ac-0dc4ddbf2f74.pdf) |
| 2025-11-17 | [Results For The Half Year Ended 30-09-2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4316a75f-1b18-4df7-979a-a7fbf87276e6.pdf) |
| 2025-08-14 | [Financial Results For The Quarter Ended 30.06.2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8c693570-4c1c-4f08-9b11-c86ba4fdfbb0.pdf) |
| 2025-05-28 | [Financial Results For The Quarter And Year Ended 31.03.2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ac8dbc01-3d2f-4e87-b5f6-544fb81a3e85.pdf) |
| 2025-02-12 | [Outcome Of Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0992cec5-5629-4a73-b7ae-2cb29a201676.pdf) |
| 2024-11-05 | [Outcome Of Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=afa8d0d6-f467-415b-8928-19da265784c4.pdf) |
| 2024-05-28 | [Outcome Of Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5fe4e4c9-78ef-4a3c-860e-5d0076b2204c.pdf) |
| 2024-02-13 | [Financial Results For The Quarter Ended 31St December 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9bbeebda-a583-4c63-9a40-a89b9226baed.pdf) |
| 2023-11-09 | [Outcome Of Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dfca4398-d1a1-4ae6-acc8-8e1814e64508.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 6 Feb - 06 Feb 2026 EGM approved share capital reduction, higher borrowings, security creation, and two independent director appointments. | [Shareholder Meeting / Postal Ballot-Outcome of EGM 6 Feb - 06 Feb 2026 EGM approved share capital reduction, higher borrowings, security creation, and two independent director appointments.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/df83c1ff-7b4b-4ed3-8c61-d16afde68713.pdf) |
| 4 Feb - Board meeting 12 Feb 2026 to approve unaudited results for quarter ended 31 Dec 2025; trading window closed. | [Board Meeting Intimation for Notice Of Board Meeting 4 Feb - Board meeting 12 Feb 2026 to approve unaudited results for quarter ended 31 Dec 2025; trading window closed.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8edd9634-e6eb-49b6-813a-bc3000294afa.pdf) |
| 30 Apr - Submitted Regulation 74(5) certificate for quarter ended March 31, 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 30 Apr - Submitted Regulation 74(5) certificate for quarter ended March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/965a722c-b141-48af-9945-c731be4e2d8f.pdf) |
| 30 Apr - Submitted Regulation 74(5) certificate for quarter ended March 31, 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 30 Apr - Submitted Regulation 74(5) certificate for quarter ended March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/965a722c-b141-48af-9945-c731be4e2d8f.pdf) |
| 28 February 2026 - Corrigendum: preferential issue at Rs20/share to acquire 51.02% of Kesar Pharma; floor Rs9.46; voting ends 15 Mar 2026 | [Shareholders meeting 28 February 2026 - Corrigendum: preferential issue at Rs20/share to acquire 51.02% of Kesar Pharma; floor Rs9.46; voting ends 15 Mar 2026](https://nsearchives.nseindia.com/corporate/VAISHALI_28022026205013_CorrigendumwithCoverLetter.pdf) |
| 17 February 2026 - Vaishali Pharma Limited has informed about Copy of Newspaper Publication | [Copy of Newspaper Publication 17 February 2026 - Vaishali Pharma Limited has informed about Copy of Newspaper Publication](https://nsearchives.nseindia.com/corporate/VAISHALI_17022026190617_Advertisment_Postall_ballot_Signed.pdf) |
| 17 February 2026 - Board approved and published unaudited Q3 and nine-month results ended 31-Dec-2025; ad on 17 Feb 2026. | [Copy of Newspaper Publication 17 February 2026 - Board approved and published unaudited Q3 and nine-month results ended 31-Dec-2025; ad on 17 Feb 2026.](https://nsearchives.nseindia.com/corporate/VAISHALI_17022026185855_Result_Advertisment_Signed__2_.pdf) |
| 16 February 2026 - 61,23,000 shares at Rs20 to Kesar Pharma via Rs12,24,60,000 swap; Rs8,17,29,645 cash; ballot ends 15 Mar 2026. | [Shareholders meeting 16 February 2026 - 61,23,000 shares at Rs20 to Kesar Pharma via Rs12,24,60,000 swap; Rs8,17,29,645 cash; ballot ends 15 Mar 2026.](https://nsearchives.nseindia.com/corporate/VAISHALI_16022026130526_Cover_News.pdf) |
| 13 February 2026 - Board approved preferential allotment of 61,23,000 shares at ₹20 (₹12.246 crore) via swap for Kesar Pharma shares. | [Outcome of Board Meeting 13 February 2026 - Board approved preferential allotment of 61,23,000 shares at ₹20 (₹12.246 crore) via swap for Kesar Pharma shares.](https://nsearchives.nseindia.com/corporate/VAISHALI_13022026190039_Outcome_VPL_Signed.pdf) |
| 13 February 2026 - Approved Q3 results; preferential issue of 61.23 lakh shares at ₹20 (₹12.246Cr) via swap for Kesar Pharma shares. | [Outcome of Board Meeting 13 February 2026 - Approved Q3 results; preferential issue of 61.23 lakh shares at ₹20 (₹12.246Cr) via swap for Kesar Pharma shares.](https://nsearchives.nseindia.com/corporate/VAISHALI_13022026193440_Outcome_VPL_Signed.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2025 from nse](https://archives.nseindia.com/annual_reports/AR_27921_VAISHALI_2024_2025_A_8838611_29082025203354.pdf) |
| from nse | [Financial Year 2024 from nse](https://archives.nseindia.com/annual_reports/AR_25614_VAISHALI_2023_2024_0309202420324.pdf) |
| from nse | [Financial Year 2023 from nse](https://archives.nseindia.com/annual_reports/AR_23768_VAISHALI_2022_2023_07092023173316_09072023180035.zip) |
| from nse | [Financial Year 2022 from nse](https://archives.nseindia.com/annual_reports/AR_21743_VAISHALI_2021_2022_08092022201059_09082022210006.zip) |
| from nse | [Financial Year 2021 from nse](https://archives.nseindia.com/annual_reports/AR_19680_VAISHALI_2020_2021_07092021225003_09072021230003.zip) |
| from nse | [Financial Year 2020 from nse](https://archives.nseindia.com/annual_reports/AR_17477_VAISHALI_2019_2020_07092020021518_07092020070002.zip) |
| from nse | [Annual Report 2013 from nse](https://archives.nseindia.com/annual_reports/AR_1852_BLUECHIP_2012_2013_18092013161215.zip) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/07d9eae9-ff22-449d-8158-715fc1c0b092.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/70940d42-b91f-4bbe-a133-0dbc0a9b2f93.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9858bd79-8102-41ee-a7ad-5937f61f56f8.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2023 | [Concall - Nov 2023](https://nsearchives.nseindia.com/corporate/VAISHALI_29112023172034_Investor_Meet_Result.pdf) |
| May 2020 | [Concall - May 2020](https://archives.nseindia.com/corporate/VAISHALI_28052020090759_Vaishali_Pharma_Limited_Investor_Presentation_May_2020.pdf) |
| Feb 2024 | [Concall - Feb 2024](https://nsearchives.nseindia.com/corporate/VAISHALI_09022024183502_Investor_Meet_Transcript.pdf) |
| Aug 2020 | [Concall - Aug 2020](https://archives.nseindia.com/corporate/VAISHALI_06082020145314_Investor_Presentation_August_2020.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:45:08.863Z.